|
1
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Badoual C: Update from the 5th edition of
the World Health Organization classification of head and neck
tumors: Oropharynx and nasopharynx. Head Neck Pathol. 16:19–30.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang HY, Chang YL, To KF, Hwang JS, Mai
HQ, Feng YF, Chang ET, Wang CP, Kam MK, Cheah SL, et al: A new
prognostic histopathologic classification of nasopharyngeal
carcinoma. Chin J Cancer. 35:412016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mete O and Wenig BM: Update from the 5th
edition of the World Health Organization classification of head and
neck tumors: Overview of the 2022 WHO classification of head and
neck neuroendocrine neoplasms. Head Neck Pathol. 16:123–142. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee LY, Chang KP, Hsu CL, Chen TC and Kuo
TT: Small-cell neuroendocrine carcinoma of the nasopharynx: Report
of a rare case lacking association with Epstein-Barr virus. Int J
Surg Pathol. 19:199–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weinreb I and Perez-Ordonez B: Non-small
cell neuroendocrine carcinoma of the sinonasal tract and
nasopharynx. Report of 2 cases and review of the literature. Head
Neck Pathol. 1:21–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin IH, Hwang CF, Huang HY and Chien CY:
Small cell carcinoma of the nasopharynx. Acta Otolaryngol.
127:206–208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galera-Ruiz H, Villar-Rodriguez JL,
Sanchez-Calzado JA, Martin-Mora J and Ruiz-Carmona E: Sinonasal
neuroendocrine carcinoma presenting as a nasopharyngeal mass.
Otolaryngol Head Neck Surg. 124:475–476. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou YL, Peng YP, Liu QD, Chen XZ, He J,
Wei W, Zhong GH, Zhang YQ, Liu Y, Pan JY, et al: Clinical
characteristics and prognosis of small cell carcinoma in the
nasopharynx: A population-based study. Cancer Control.
29:107327482210870752022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du YR, Guo CY, Yuan P, Zhang J and Ying
JM: Epstein-Barr virus-positive large cell neuroendocrine carcinoma
of the nasopharynx: Report of a case. Zhonghua Bing Li Xue Za Zhi.
50:530–532. 2021.(In Chinese). PubMed/NCBI
|
|
11
|
Teinor J, Groshek L and He J: Rare case of
metastatic small cell carcinoma of the nasopharynx to the pancreas.
BMJ Case Rep. 13:e2350542020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mesolella M, Allosso S, Varricchio S,
Russo D, Pignatiello S, Buono S and Motta G: Small-cell carcinoma
of nasopharynx: A case report of unusual localization. Ear Nose
Throat J. 1455613209737802020.(Epub ahead of print). PubMed/NCBI
|
|
13
|
Cai Z, Lin M, Blanco AI, Liu J and Zhu H:
Epstein-Barr virus-positive large cell neuroendocrine carcinoma of
the nasopharynx: Report of one case and review of the literature.
Head Neck Pathol. 13:313–317. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhardwaj N, Kakkar A and Irugu DVK: Small
cell neuroendocrine carcinoma: A rare nasopharyngeal malignancy
with aggressive clinical course. Indian J Otolaryngol Head Neck
Surg. 70:454–458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wasserman JK, Papp S, Hope AJ and
Perez-Ordóñez B: Epstein-Barr virus-positive large cell
neuroendocrine carcinoma of the nasopharynx: Report of a case with
complete clinical and radiological response after combined
chemoradiotherapy. Head Neck Pathol. 12:587–591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Azevedo D, Rios E, Vendeira L and Sarmento
C: Small cell neuroendocrine carcinoma of the nasopharynx: A rare
case report. Autops Case Rep. 7:31–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bellahammou K, Lakhdissi A, Akkar O,
Kouhen F, Rais F, Dahraoui S, M'rabti H and Errihani H: Small-cell
neuroendocrine carcinoma of nasopharynx: A case report. Int J Surg
Med. 3:132–135. 2017. View Article : Google Scholar
|
|
18
|
Takahashi S, Miyashita T, Hoshikawa H,
Haba R, Togami T and Shibata T: Accelerated hyperfractionated
radiotherapy for small cell carcinoma of the nasopharynx. Head
Neck. 37:E63–E65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sturgis CD, Burkey BB, Momin S and Hoschar
AP: High grade (large cell) neuroendocrine carcinoma of the
nasopharynx: Novel case report with touch preparation cytology and
positive EBV encoded early RNA. Case Rep Pathol.
2015:2310702015.PubMed/NCBI
|
|
20
|
Lin CH, Chiang TP, Shum WY, Hsu CH, Tsai
YC, Tsao TY and Su CC: Primary small cell neuroendocrine carcinoma
of the nasal cavity after successful curative therapy of
nasopharyngeal carcinoma: A case report. Kaohsiung J Med Sci.
25:145–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deviprasad S, Rajeshwari A, Tahir M,
Adarsha TV and Gangadhara S: Small-cell neuroendocrine carcinoma
originating from the lateral nasopharyngeal wall. Ear Nose Throat
J. 87:E1–E3. 2008.PubMed/NCBI
|
|
22
|
Ma W, Betts G, Dykes M, St Leger D,
Sargent A, Shelton D, Holbrook M and Rana D: Human
papillomavirus-associated small cell carcinoma with synchronous
squamous cell carcinoma in the nasopharynx: Report of a rare case.
Cytopathology. 32:385–388. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weiss LM and Chen YY: EBER in situ
hybridization for Epstein-Barr virus. Methods Mol Biol.
999:223–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Menon SS, Guruvayoorappan C, Sakthivel KM
and Rasmi RR: Ki-67 protein as a tumour proliferation marker. Clin
Chim Acta. 491:39–45. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi Z, Jiang W, Chen X, Xu M, Wang X and
Zha D: Prognostic and clinicopathological value of Ki-67 expression
in patients with nasopharyngeal carcinoma: A meta-analysis. Ther
Adv Med Oncol. 12:17588359209513462020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin H, Qu J, Peng Q and Gan R: Molecular
mechanisms of EBV-driven cell cycle progression and oncogenesis.
Med Microbiol Immunol. 208:573–583. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsao SW, Tsang CM and Lo KW: Epstein-Barr
virus infection and nasopharyngeal carcinoma. Philos Trans R Soc
Lond B Biol Sci. 372:201602702017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng X, Zhou Y, Tao Y and Liu S:
Nasopharyngeal carcinoma: The role of the EGFR in Epstein-Barr
virus infection. Pathogens. 10:11132021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang LL, Chen YP, Chen CB, Chen MY, Chen
NY, Chen XZ, Du XJ, Fang WF, Feng M, Gao J, et al: The Chinese
society of clinical oncology (CSCO) clinical guidelines for the
diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun
(Lond). 41:1195–1227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim KY, Le QT, Yom SS, Pinsky BA, Bratman
SV, Ng RH, El Mubarak HS, Chan KC, Sander M and Conley BA: Current
state of PCR-based Epstein-Barr virus DNA testing for
nasopharyngeal cancer. J Natl Cancer Inst. 109:djx0072017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Le QT, Zhang Q, Cao H, Cheng AJ, Pinsky
BA, Hong RL, Chang JT, Wang CW, Tsao KC, Lo YD, et al: An
international collaboration to harmonize the quantitative plasma
Epstein-Barr virus DNA assay for future biomarker-guided trials in
nasopharyngeal carcinoma. Clin Cancer Res. 19:2208–2215. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang R, Yang L and Zhu X: Nimotuzumab, an
anti-EGFR monoclonal antibody, in the treatment of nasopharyngeal
carcinoma. Cancer Control. 28:10732748219893012021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Smyth JF, Smith IE, Sessa C, Schoffski P,
Wanders J, Franklin H and Kaye SB: Activity of docetaxel (Taxotere)
in small cell lung cancer. The early clinical trials group of the
EORTC. Eur J Cancer. 30A:1058–1060. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smit EF, Fokkema E, Biesma B, Groen HJ,
Snoek W and Postmus PE: A phase II study of paclitaxel in heavily
pretreated patients with small-cell lung cancer. Br J Cancer.
77:347–351. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masters GA, Temin S, Azzoli CG, Giaccone
G, Baker SJ Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller
JH, et al: Systemic therapy for stage IV non-small-cell lung
cancer: American society of clinical oncology clinical practice
guideline update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chinese Medical Association Oncology
Branch, . Lung Cancer Clinical Guidelines for Diagnosis and
Treatment (2021 Edition). Chinese Journal of Oncology. 43:591–621.
2021.PubMed/NCBI
|
|
37
|
Pfister DG, Spencer S, Adelstein D, Adkins
D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ,
et al: Head and neck cancers, version 2.2020, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
18:873–898. 2020. View Article : Google Scholar : PubMed/NCBI
|
